Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HealthTronics closes AMPI buy:

This article was originally published in Clinica

Executive Summary

In a bid to diversify its urology product line, HealthTronics has bought urological cryosurgery specialist Advanced Medical Partners (AMPI) for an undisclosed fee. The deal saw HealthTronics pay a cash-and-stock mix to AMPI at the closing - AMPI will also receive performance-related earn-out payments. AMPI recorded revenues of over $24m in 2007. According to Austin, Texas-based HealthTronics, this acquisition will make it the largest provider of shock wave lithotripsy and cryosurgery services in the US. HealthTronics said it expects AMPI to provide top- and bottom- line synergies, thus enabling cost savings. In conjunction with the acquisition, HealthTronics also announced 2008 revenue guidance of $160-162m, and an operating profit target of $20-21m.

You may also be interested in...



Listerine, Tylenol Push J&J Consumer Health To 2020 Finish Line Against Pandemic Weight

Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.

NB Pure Rolls Out As Brand For Sharpening Consumer Attention On Natural Wellness Line

Nutritional Brands rolls out NB Pure as brand, including logo, packaging design and website, for all its supplements after 25 years. “When you looked at our label for one brand and looked at the label for another brand, there was no symmetry between the two,” says CEO Danna Pratt.

Sanofi Steps Up To Lend A Hand Producing Pfizer/BioNTech's COVID-19 Vaccine In Europe

Sanofi will fill and package 100 million doses of a rival vaccine for the European market in 2021 in a sign of how the industry is working to meet an unprecedented demand for COVID-19 vaccines.

Topics

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel